Does pharmacomechanical catheter-directed thrombolysis reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis?
Patients with proximal deep-vein thrombosis
Pharmacomechanical catheter-directed thrombolysis
Post-thrombotic syndrome
Pharmacomechanical catheter-directed thrombolysis is hypothesized to reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis.
The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheterdirected thrombolysis (hereafter "pharmacomechanical thrombolysis") rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome.
Building similarity graph...
Analyzing shared references across papers
Loading...
Suresh Vedantham
Vascular Medicine
Samuel Z. Goldhaber
Vascular Medicine
Jim A. Julian
Vascular Medicine
New England Journal of Medicine
Harvard University
University of Michigan
University of California, Los Angeles
Building similarity graph...
Analyzing shared references across papers
Loading...
Vedantham et al. (Wed,) studied this question.
synapsesocial.com/papers/69d8afdcd2f7327e70ae3f98 — DOI: https://doi.org/10.1056/nejmoa1615066